Riskpilot← Back to searchSign inGet full accessLugnetkliniken Sverige AB
ABActiveOrg 5591545271Lindbergsvägen 2 CGeneral medical practice activities · NACE 8621Est. 201811 employees
Revenue 2024
SEK 17M
+31% vs 2023
EBITDA margin
23.5%
+124% vs 2023
Equity ratio
55.9%
Financial strength
Net profit 2024
SEK 3,1M
+135% vs 2023
| Revenue | SEK 17M | +31% |
| EBITDA | SEK 4M | +124% |
| Net profit | SEK 3,1M | +135% |
| Total assets | SEK 7,3M | +126% |
| Equity | SEK 4,1M | +172% |
| Employees | 11 | — |
Legal name
Lugnetkliniken Sverige AB
Org number
5591545271
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 april 2018
Share capital
SEK 50 000
Employees
11 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget kommer att bedriva vårdcentral, ta emot konsultationer av andra kliniker, arbeta som hyrläkare och medicinsk konsult samt därmed förenlig verksamhet.
Address
Lindbergsvägen 2 C
Email
nebrass.mahmoud@lugnetkliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 | 1 022 | 8 299 | 12 999 | 17 028 |
| Staff expenses | — | — | −3 366 | −7 521 | −9 248 |
| EBITDA | −10 | −877 | −272 | 1 792 | 4 010 |
| Depreciation & amort. | −0 | −130 | −130 | −130 | −130 |
| EBIT | −10 | −1 007 | −402 | 1 661 | 3 879 |
| Net financials | — | — | −1 | −2 | −2 |
| Profit before tax | −10 | 43 | 147 | 1 659 | 3 878 |
| Tax | −0 | −9 | −9 | −355 | −815 |
| Net profit | −10 | 34 | 138 | 1 304 | 3 062 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 50 | 720 | 1 520 | 3 207 | 7 256 |
| Equity | 50 | 84 | 188 | 1 493 | 4 055 |
| Long-term debt | 0 | 450 | 350 | 0 | — |
| Short-term debt | 0 | 186 | 982 | 1 715 | 3 201 |
| Total debt | — | 636 | 1 332 | 1 715 | 3 201 |
EBITDA margin
23.5%
This company
15.8%
Market median
+49% vs market
20202024
Equity ratio
55.9%
This company
38.2%
Market median
+46% vs market
20202024
Return on equity
75.5%
This company
18.4%
Market median
+310% vs market
20202024
Net profit margin
18.0%
This company
8.1%
Market median
+122% vs market
20202024
Asset turnover
2.35×
This company
1.12×
Market median
+110% vs market
20202024
Debt / equity
0.79×
This company
0.62×
Market median
+27% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2024 | |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Prof-care Sverige AB
Lugnetkliniken Sverige AB Board members of Lugnetkliniken Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anton Lars Alexander Berggren | Audit | 0 companies |
| Nebrass Kamel Mahmoud | Board of Directors | 0 companies |
| Sven Anders Lennart Svensson | Deputy Board Member | 0 companies |
| Sunbel Nadhem Amin | Deputy Board Member | 0 companies |